Skip to content

TherapeuticsMD, Inc.

TXMD

CIK 0000025743

← back to feed
Revenue (TTM)
$1.15M
+274.6% YoY Q1 May 2026
Net Income (TTM)
$145K
+73.9% YoY Q1 May 2026
EPS Diluted (TTM)
$0.01
+73.7% YoY Q1 May 2026
Gross Margin
69.3%
Q1 May 2026
Operating Margin
-308.6%
Q1 May 2026
Net Margin
12.6%
Q1 May 2026
Free Cash Flow (TTM)
−$104.45M
Q1 May 2026
Cash
$5.75M
Q1 May 2026
Total Debt
$93.6M
Q1 May 2026
Shares Outstanding
11.57M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings